Yahoo

Mail

Deutsche Märkte öffnen in 1 Stunde 48 Minute

Nikkei 225
38.773,02
+536,95(+1,40%)
Dow Jones 30
38.852,27
+176,59(+0,46%)
Bitcoin EUR
58.907,68
-637,02(-1,07%)
CMC Crypto 200
1.363,64
+51,02(+3,89%)
Nasdaq Compositive
16.349,25
+192,92(+1,19%)
S&P 500
5.180,74
+52,95(+1,03%)

Sensei Biotherapeutics, Inc. (SNSE)

NasdaqGM - NasdaqGM Echtzeitpreis. Währung in USD

Zur Watchlist hinzufügen

1,8400

+0,0500

(+2,79%)

Börsenschluss: 04:00PM EDT

1,8584

+0,02

(+1,00%)

Nachbörse:

07:06PM EDT

Hauptinhaber

Insider

Insider-Transaktionen

Währung in USD

Insider-Käufe (letzte 6 Monate)	Aktien	Trans
Käufe	0	0
Verkauf	N/A	0
Gekaufte Nettoaktien (verkauft)	0	0
Insideraktien mit Beteiligung (gesamt)	8,68M	N/A
% Gekaufte Nettoaktien (verkauft)	N/A	N/A

Institutionelle Käufe (netto) der letzten Quartale	Aktien
Gekaufte Nettoaktien (verkauft)	N/A
% Schwankung in institutioneller Aktienbeteiligung	N/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

Insider	Transaktion	Typ	Wert	Datum	Aktien
CELEBI JOHN Chief Executive Officer	Purchase at price 0.85 per share.	Direkt	425	11. Sept. 2023	500
BRODER SAMUEL Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
RICKS THOMAS GREGORY Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirekt	0	10. Juli 2023	4.466
VOJTA DENEEN Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
HOLMEN BOB Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
ENGLISH JESSIE Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
HUMER KRISTIAN Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
RINGO WILLIAM R Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juli 2023	4.466
APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 1.58 per share.	Indirekt	5.437.824	01. Juni 2023	3.441.661
APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.60 - 1.61 per share.	Indirekt	3.539	23. Feb. 2023	2.200
CELEBI JOHN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	73.193
CELEBI JOHN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	73.193
COLGAN ERIN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	51.346
COLGAN ERIN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	51.346
GALLAGHER PATRICK STEPHEN Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	43.513
GALLAGHER PATRICK STEPHEN Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	43.513
VAN-DER HORST EDWARD Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2023	41.265
BRODER SAMUEL Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
RICKS THOMAS GREGORY Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirekt	0	10. Juni 2022	4.466
VOJTA DENEEN Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
HOLMEN BOB Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
ENGLISH JESSIE Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
HUMER KRISTIAN Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	10. Juni 2022	4.466
RINGO WILLIAM R Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	08. März 2022	18.933
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Indirekt	3.850	02. März 2022	1.203
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Indirekt	3.850	02. März 2022	1.203
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Direkt	3.850	02. März 2022	1.203
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Direkt	3.850	02. März 2022	1.203
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Indirekt	9.000	01. März 2022	2.500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Direkt	9.000	01. März 2022	2.500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.65 per share.	Indirekt	9.125	25. Feb. 2022	2.500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.65 per share.	Indirekt	9.125	25. Feb. 2022	2.500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.63 - 3.80 per share.	Indirekt	63.950	24. Feb. 2022	17.500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.63 - 3.80 per share.	Indirekt	63.950	24. Feb. 2022	17.500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.97 - 4.17 per share.	Indirekt	80.187	18. Feb. 2022	19.949
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.97 - 4.17 per share.	Indirekt	80.187	18. Feb. 2022	19.949
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.18 - 4.25 per share.	Indirekt	52.642	16. Feb. 2022	12.551
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.18 - 4.25 per share.	Indirekt	52.642	16. Feb. 2022	12.551
PIERCE ROBERT HAMILTON Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2022	21.000
CELEBI JOHN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2022	53.900
COLGAN ERIN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Feb. 2022	21.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.40 - 4.58 per share.	Indirekt	77.900	11. Feb. 2022	17.500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.40 - 4.58 per share.	Direkt	77.900	11. Feb. 2022	17.500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.33 - 4.65 per share.	Indirekt	135.800	08. Feb. 2022	30.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.33 - 4.65 per share.	Direkt	135.800	08. Feb. 2022	30.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.22 - 4.31 per share.	Indirekt	63.849	28. Jan. 2022	15.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.22 - 4.31 per share.	Direkt	63.849	28. Jan. 2022	15.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.62 - 4.86 per share.	Indirekt	235.824	26. Jan. 2022	50.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.62 - 4.86 per share.	Direkt	235.824	26. Jan. 2022	50.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.69 - 4.94 per share.	Indirekt	228.529	24. Jan. 2022	47.410
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.69 - 4.94 per share.	Direkt	228.529	24. Jan. 2022	47.410
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.97 - 5.17 per share.	Indirekt	154.313	20. Jan. 2022	30.244
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.97 - 5.17 per share.	Direkt	154.313	20. Jan. 2022	30.244
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.08 per share.	Indirekt	50.800	18. Jan. 2022	10.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.08 per share.	Direkt	50.800	18. Jan. 2022	10.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.99 - 5.13 per share.	Indirekt	133.392	14. Jan. 2022	26.172
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.99 - 5.13 per share.	Direkt	133.392	14. Jan. 2022	26.172
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.18 - 5.22 per share.	Indirekt	104.212	12. Jan. 2022	20.047
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.18 - 5.22 per share.	Direkt	104.212	12. Jan. 2022	20.047
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Indirekt	52.800	10. Jan. 2022	10.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Direkt	52.800	10. Jan. 2022	10.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.85 per share.	Indirekt	5.466	30. Dez. 2021	1.127
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.85 per share.	Direkt	5.466	30. Dez. 2021	1.127
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirekt	343.620	29. Dez. 2021	69.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Direkt	343.620	29. Dez. 2021	69.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Indirekt	59.601	28. Dez. 2021	11.288
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Direkt	59.601	28. Dez. 2021	11.288
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.30 per share.	Indirekt	19.674	27. Dez. 2021	3.712
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.30 per share.	Direkt	19.674	27. Dez. 2021	3.712
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.27 per share.	Indirekt	57.970	23. Dez. 2021	11.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.27 per share.	Direkt	57.970	23. Dez. 2021	11.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.29 per share.	Indirekt	619	17. Dez. 2021	117
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.29 per share.	Direkt	619	17. Dez. 2021	117
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.25 per share.	Indirekt	57.356	16. Dez. 2021	10.925
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.25 per share.	Direkt	57.356	16. Dez. 2021	10.925
RICKS THOMAS GREGORY Director	Purchase at price 5.86 - 6.62 per share.	Indirekt	249.600	10. Dez. 2021	40.000
PIERCE ROBERT HAMILTON Officer	Sale at price 7.34 per share.	Indirekt	117.718	11. Aug. 2021	16.030
PIERCE ROBERT HAMILTON Officer	Sale at price 7.06 - 7.13 per share.	Indirekt	568.246	10. Aug. 2021	79.792
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirekt	4.200	05. Mai 2021	350
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Direkt	4.200	05. Mai 2021	350
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.77 per share.	Indirekt	4.916	20. Apr. 2021	385
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.77 per share.	Direkt	4.916	20. Apr. 2021	385
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.38 per share.	Indirekt	26.292	19. Apr. 2021	1.965
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.38 per share.	Direkt	26.292	19. Apr. 2021	1.965
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirekt	28.000	13. Apr. 2021	2.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Direkt	28.000	13. Apr. 2021	2.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirekt	28.000	07. Apr. 2021	2.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirekt	28.000	07. Apr. 2021	2.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirekt	14.000	01. Apr. 2021	1.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirekt	14.000	01. Apr. 2021	1.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirekt	24.000	30. März 2021	2.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirekt	24.000	30. März 2021	2.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 per share.	Indirekt	52.950	24. März 2021	3.750
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 per share.	Direkt	52.950	24. März 2021	3.750
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Indirekt	143.400	23. März 2021	10.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Indirekt	136.230	23. März 2021	9.500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Direkt	143.400	23. März 2021	10.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Direkt	136.230	23. März 2021	9.500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.02 per share.	Indirekt	32.789	22. März 2021	2.183
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.02 per share.	Direkt	32.789	22. März 2021	2.183
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Indirekt	12.459	18. März 2021	817
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Direkt	12.459	18. März 2021	817
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Indirekt	15.249	08. März 2021	1.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Direkt	15.249	08. März 2021	1.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.75 per share.	Indirekt	110.000	05. März 2021	8.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.75 per share.	Indirekt	110.000	05. März 2021	8.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 - 15.85 per share.	Indirekt	75.800	04. März 2021	5.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 - 15.85 per share.	Indirekt	75.800	04. März 2021	5.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirekt	48.750	02. März 2021	3.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirekt	48.750	02. März 2021	3.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirekt	81.250	26. Feb. 2021	5.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirekt	81.250	26. Feb. 2021	5.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.79 - 18.42 per share.	Indirekt	510.862	25. Feb. 2021	31.000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.79 - 18.42 per share.	Indirekt	510.862	25. Feb. 2021	31.000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.04 - 18.10 per share.	Indirekt	361.070	23. Feb. 2021	20.300
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.04 - 18.10 per share.	Direkt	361.070	23. Feb. 2021	20.300
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.88 per share.	Indirekt	185.062	22. Feb. 2021	9.802
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.88 per share.	Indirekt	185.062	22. Feb. 2021	9.802
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.77 per share.	Indirekt	233.009	19. Feb. 2021	11.786
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.77 per share.	Indirekt	233.009	19. Feb. 2021	11.786
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Indirekt	14.872	18. Feb. 2021	753
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Indirekt	14.852	18. Feb. 2021	752
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Indirekt	14.872	18. Feb. 2021	753
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Direkt	14.852	18. Feb. 2021	752
RICKS THOMAS GREGORY Director		Indirekt		08. Feb. 2021	301.769
H&S INVESTMENTS I L P Beneficial Owner of more than 10% of a Class of Security		Indirekt		08. Feb. 2021	4.361.835
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security		Indirekt		08. Feb. 2021	2.407.328
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security		Indirekt		08. Feb. 2021	2.407.328

Nikkei 22538.773,02+536,95(+1,40%)

Dow Jones 3038.852,27+176,59(+0,46%)

Bitcoin EUR58.907,68-637,02(-1,07%)

CMC Crypto 2001.363,64+51,02(+3,89%)

Nasdaq Compositive16.349,25+192,92(+1,19%)

S&P 5005.180,74+52,95(+1,03%)

Sensei Biotherapeutics, Inc. (SNSE)

Insider-Transaktionen

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

Nikkei 225
38.773,02
+536,95(+1,40%)

Dow Jones 30
38.852,27
+176,59(+0,46%)

Bitcoin EUR
58.907,68
-637,02(-1,07%)

CMC Crypto 200
1.363,64
+51,02(+3,89%)

Nasdaq Compositive
16.349,25
+192,92(+1,19%)

S&P 500
5.180,74
+52,95(+1,03%)